Quality of Life Research

, Volume 9, Issue 1, pp 39–53 | Cite as

Measuring the impact of onychomycosis on patient quality of life

  • Ralph R. Turner
  • Marcia A. Testa
Article

Abstract

According to survey research, onychomycosis, a fungal infection of the toenail or fingernail, affects quality of life including physical and social functioning and emotional health. We developed an onychomycosis disease-specific questionnaire (ODSQ) that sensitively assessed symptom distress, functional impact, and social stigma associated with the disease. Samples of patients enrolled in a randomized controlled clinical trial were used for the psychometric evaluations. The multi-item scales were internally consistent (α ≥ 0.80) and reproducible (ICC > 0.85). Interscale correlations between the ODSQ and generic scales were moderate and consistent with the hypothesized magnitude and directions. Construct validation, employing known groups analysis, supported the hypothesized impact of onychomycosis on three domains of quality of life: physical functioning, emotional health, and social functioning. Significant differences were found between clinically “cured”, “improved”, or “failed” patients, and between mycologically “eradicated” and “persistent” patients. The ODSQ was responsive to clinical change and more sensitive than derived Medical Outcomes Study Short Form-36 scales. The ODSQ provides reliable, validated and responsive information about the consequences of onychomycosis and its treatment.

Disease-specific scale Generic scale Onychomycosis Quality of life Reliability Responsiveness Validity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zaias N, Glick B, Rebell G. Diagnosing and treating onychomycosis. J Fam Pract 1996; 42: 513–518.Google Scholar
  2. 2.
    Clayton YM. Clinical and mycological diagnostic aspects of onychomycosis and dermatomycoses. Clin Exp Dermatol 1992; 17: 37–40.Google Scholar
  3. 3.
    Scher RK. Onychomycosis: A significant medical disorder. J Am Acad Dermatol 1996; 35: S2–S5.Google Scholar
  4. 4.
    Drake LA. Impact of onychomycosis on quality of life. J Am Pod Med Assn 1997; 87(11): 507–511.Google Scholar
  5. 5.
    Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res 1993; 2: 341–348.Google Scholar
  6. 6.
    Drake LA, Scher RK, Smith ED, Faich GA, Smith SL, Hong JJ, Stiller MJ. Effect of onychomychosis on quality of life. J Am Acad Derm 1998; 38(5 Pt. 1): 702–704.Google Scholar
  7. 7.
    Elewski BE. The effect of toenail onychomycosis on patient quality of life. Int J Derm 1997; 36: 754–756.Google Scholar
  8. 8.
    Guess HA. Measuring disease-specific quality of life in men with benign prostatic hyperplasia. In: Spilker B, ed, Quality of life and pharmacoeconomics in clinical trials (2nd Ed). Lippincott-Raven, 1996: 945–952.Google Scholar
  9. 9.
    Patrick DI, Erickson PE. Health status and health policy – allocating resources to health care. New York: Oxford University Press, 1993: 138–143.Google Scholar
  10. 10.
    Testa M, Simonson D. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835–840.Google Scholar
  11. 11.
    Testa M, Anderson R, Nackley J, et al. Quality of life and antihypertensive therapy in men: a comparison of captopril with enalapril. N Engl J Med 1993; 328: 907–913.Google Scholar
  12. 12.
    Testa MA, Simonson DC, Turner RR. Valuing quality of life improvements in glycemic control in people with type 2 diabetes. Diabetes Care (in press).Google Scholar
  13. 13.
    Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus – a randomized, controlled, double-blind trial. JAMA 1998; 280: 1490–1496.Google Scholar
  14. 14.
    Stewart A, Ware J, eds. Measuring functioning and well-being – the medical outcomes study approach. Durham, NC: Duke University Press, 1992.Google Scholar
  15. 15.
    Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey. Manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.Google Scholar
  16. 16.
    Cronbach LJ. Coefficient alpha and internal structure of tests. Psychometrika 1951; 16: 297–334.Google Scholar
  17. 17.
    Winer BJ. Statistical principles in experimental design (2nd Ed). New York: McGraw-Hill, 1971: 283–296.Google Scholar
  18. 18.
    Tatsuoka M. Multivariate analysis – techniques for educational and psychological research. New York: John Wiley & Sons, 1971: 194–216.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Ralph R. Turner
    • 1
    • 2
  • Marcia A. Testa
    • 1
    • 2
  1. 1.Phase V Technologies, Inc.Wellesley Hills
  2. 2.Harvard School of Public HealthBoston

Personalised recommendations